Save the Date
ASDP 63rd Annual Meeting
November 19-22, 2026
Omni Atlanta Hotel at Centennial Park
Atlanta, Georgia USA
**Call for Abstracts will be opening July 15, 2026.
About the Call for Abstracts
The ASDP Call for Abstracts offers three categories of abstract submissions for participants interested in presenting their abstract(s) in an educational session at the Annual Meeting.
- The General Abstract category is open to all physicians who practice dermatopathology, including medical students, and residents. Abstracts will be selected for either oral or poster presentation.
- The Duel in Dermatopathology category is an oral abstract competition designed especially for residents in dermatology and pathology. Duel abstracts not selected for the competition will be automatically considered for poster presentation.
- The Dermatopathology Fellows Abstract category is open to fellows in a dermatopathology training program. Abstracts will be selected for either oral or poster presentation.
There is no limit on the number of abstracts per submitter. All abstracts should be written with the goal of bringing new or updated information to attendees or providing an organized review of older data. The Abstract Review Committee will select all abstract presentations through a blinded review process. Abstract criteria are subject to annual review.
Abstract Submission Criteria
Abstract submissions must adhere to the published submission criteria:
- Abstract content must be dermatopathology-related, medically and scientifically valid, and should contain new information not previously reported or novel information about the pathophysiology or diagnosis that enhances the understanding of the disease.
- Abstracts with authors who are owners or employees of ineligible companies* must meet at least one of the following requirements:
- The content of the abstract must not be related to the business lines or products of the employer/company.
- The content of the abstract must be limited to basic science research, such as pre-clinical research and drug discovery, or the methodologies of research, and must not make care recommendations.
- The content of the abstract must be limited to teaching safe and proper use of medical devices, tests, etc., and must not make recommendations whether or when a device/test is used.
- Abstract content must not have been previously presented, submitted, or accepted for presentation at another meeting or previously published in any journal. Abstract content that has been accepted for publication but has not yet been published may be submitted. If work has been published by the time of presentation, this information must be disclosed at the time of presentation to the audience.
- The same abstract may not be submitted in more than one category. Submissions in the General, Duel and Fellow abstract categories will be automatically considered for a poster if not accepted as an oral presentation. Submissions to the General abstract category may be made as “poster-only” for those who prefer not to be considered for oral presentation.
- Abstract titles must be clear and accurately reflect the content of the abstract.
- Abstracts must adequately summarize the key scientific content of the presentations.
- The hypothesis should be clearly stated.
- Scientific methods must be sound and clearly articulated.
- Appropriate data and observations should be clearly presented.
- Results must be clearly presented and conclusions must accurately reflect the results and directly address the hypothesis.
- Institutions and personal or institutional identifiers must not be referenced in the abstract.
- All financial relationships in the past 24 months must be disclosed at the time of abstract submission and must be mitigated prior to abstract being accepted for presentation. Financial relationships must not introduce bias in the study design.
- The content must be free of grammatical and spelling errors.
- Non-scientific abstracts will be evaluated on a case-by-case basis.
*The Accreditation Council of Continuing Medical Education (ACCME) defines Ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Examples of such organizations include:
- Advertising, marketing, or communication firms whose clients are ineligible companies
- Bio-medical startups that have begun a governmental regulatory approval process
- Compounding pharmacies that manufacture proprietary compounds
- Device manufacturers or distributors
- Diagnostic labs that sell proprietary products
- Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
- Manufacturers of health-related wearable products
- Pharmaceutical companies or distributors
- Pharmacy benefit managers
- Reagent manufacturers or sellers
More details to come...